These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36733344)

  • 1. Identification of m6a-related signature genes in esophageal squamous cell carcinoma by machine learning method.
    Shang QX; Kong WL; Huang WH; Xiao X; Hu WP; Yang YS; Zhang H; Yang L; Yuan Y; Chen LQ
    Front Genet; 2023; 14():1079795. PubMed ID: 36733344
    [No Abstract]   [Full Text] [Related]  

  • 2. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer.
    Xu LC; Pan JX; Pan HD
    Cancer Manag Res; 2020; 12():5385-5394. PubMed ID: 32753956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of clinical prognostic features of esophageal cancer based on m6A regulators.
    Wang H; Zhang Y; Chen L; Liu Y; Xu C; Jiang D; Song Q; Wang H; Wang L; Lin Y; Chen Y; Chen J; Xu Y; Hou Y
    Front Immunol; 2022; 13():950365. PubMed ID: 36159855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the prognosis of esophageal squamous cell carcinoma based on The Cancer Genome Atlas (TCGA) of m6A methylation-associated genes.
    Pu Y; Lu X; Yang X; Yang Y; Wang D; Li M; Guan W; Xu M
    J Gastrointest Oncol; 2022 Feb; 13(1):1-12. PubMed ID: 35284129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma.
    Li MX; Sun XM; Cheng WG; Ruan HJ; Liu K; Chen P; Xu HJ; Gao SG; Feng XS; Qi YJ
    BMC Cancer; 2021 Aug; 21(1):906. PubMed ID: 34372798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma.
    Pan J; Xu L; Pan H
    Front Oncol; 2020; 10():1444. PubMed ID: 32974164
    [No Abstract]   [Full Text] [Related]  

  • 8. Comprehensive analysis of m6A RNA methylation regulators in esophageal carcinoma.
    Yang H; Liu J; Li L; Wang X; Li Z
    Transl Cancer Res; 2024 Jan; 13(1):381-393. PubMed ID: 38410211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
    Shen C; Liu J; Yang X; Jiao W; Wang Y
    Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell mapping of N6-methyladenosine in esophageal squamous cell carcinoma and exploration of the risk model for immune infiltration.
    Nie Y; Yao G; Xu X; Liu Y; Yin K; Lai J; Li Q; Zhou F; Yang Z
    Front Endocrinol (Lausanne); 2023; 14():1155009. PubMed ID: 37025404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinoma.
    Wang Z; Zhang M; Seery S; Zheng G; Wang W; Zhao Y; Wang X; Zhang Y
    Oncol Lett; 2022 Aug; 24(2):250. PubMed ID: 35761938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis.
    Miao C; Fang X; Chen Y; Zhao Y; Guo Q
    Medicine (Baltimore); 2021 Dec; 100(49):e27689. PubMed ID: 34889221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of m6A/m5C-related lncRNA signature for prediction of prognosis and immunotherapy efficacy in esophageal squamous cell carcinoma.
    Wang J; Ren H; Xu C; Yu B; Cai Y; Wang J; Ni X
    Sci Rep; 2024 Apr; 14(1):8238. PubMed ID: 38589454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a m
    Zhao X; Cui L
    Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
    Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
    Front Genet; 2022; 13():872186. PubMed ID: 35937991
    [No Abstract]   [Full Text] [Related]  

  • 16. m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma.
    Li F; Wang H; Huang H; Zhang L; Wang D; Wan Y
    Front Genet; 2020; 11():994. PubMed ID: 33193582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network analysis of miRNA targeting m6A-related genes in patients with esophageal cancer.
    Li L; Xie R; Wei Q
    PeerJ; 2021; 9():e11893. PubMed ID: 34395102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
    Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y
    Front Immunol; 2023; 14():1199040. PubMed ID: 37313409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
    Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
    J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four transcription profile-based models identify novel prognostic signatures in oesophageal cancer.
    Liu T; Fang P; Han C; Ma Z; Xu W; Xia W; Hu J; Xu Y; Xu L; Yin R; Wang S; Zhang Q
    J Cell Mol Med; 2020 Jan; 24(1):711-721. PubMed ID: 31746108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.